Amgen (AMGN) Inventory Average (2009 - 2026)

Amgen (AMGN) has reported Inventory Average for 17 consecutive years, with $6.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average fell 9.59% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 9.59% YoY), while the FY2025 annual figure was $6.6 billion, down 19.94% from the prior year.
• Inventory Average came in at $6.2 billion for Q1 2026 at Amgen, down from $6.3 billion in the prior quarter.
• The five-year high for Inventory Average was $9.1 billion in Q1 2024, with the low at $4.2 billion in Q1 2022.
• Average Inventory Average over 5 years is $6.2 billion, with a median of $6.3 billion recorded in 2025.
• Across the five-year window, Inventory Average jumped 83.5% in 2024 and slipped 24.75% in 2025, its largest moves.
• Year by year, Inventory Average stood at $4.8 billion in 2022, then jumped by 50.14% to $7.3 billion in 2023, then retreated by 1.27% to $7.2 billion in 2024, then slipped by 12.46% to $6.3 billion in 2025, then slipped by 1.27% to $6.2 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $6.2 billion, $6.3 billion, and $6.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.